{"metadata": {"source": "psychonaut", "title": "Cannabidiol - PsychonautWiki", "description": "Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.", "language": "en-GB", "url": "https://m.psychonautwiki.org/wiki/CBD", "drug": "CBD", "cid": 644019, "char_count": 21724, "word_count": 3040, "doc_id": "doc_84", "num_chunks": 28, "chunk_id": "84::chunk_16", "document_index": 84, "latency_s": 0.7780542999971658, "prompt_toks": 6422, "completion_toks": 80, "relevance_score": 1.0188093e-06}, "content": "Drug: CBD | cid: 644019\nSource: psychonaut | Source description: Cannabidiol (also known as CBD and Epidiolex®) is a naturally-occurring cannabinoid found in the cannabis plant. It is one of some 113 identified cannabinoids in cannabis plants, accounting for up to 40% of the plant's extract.[1] It does not possess the same psychoactivity as tetrahydrocannabinol (THC), which is responsible for the euphoric and hallucinogenic aspects of cannabis, and is typically described as non-intoxicating.\n\n                    Text: \n                    United States: Cannabidiol is legal under the 2018 Farm Bill[37]. The rest of the cannabis plant (anything with more than 0.3% Delta-9-THC) is still under Schedule I of the Controlled Substances Act.[citation needed]\n\nExternal links\n\nCannabidiol (Wikipedia)\n\nCannabidiol (Isomer Design)\n\nCannabidiol (Drugs-Forum)\n\nProject CBD\n\nLiterature\n\nMechoulam, R., Peters, M., Murillo-Rodríguez, E., & Hanuš, L.O. (2007). Cannabidiol--recent advances. Chemistry & Biodiversity, 4 8, 1678-92.\n\nMechoulam, R., Parker, L. A., & Gallily, R. (2002). Cannabidiol: an overview of some pharmacological aspects. The Journal of Clinical Pharmacology, 42(S1).\n\nDevinsky, O., Cilio, M. R., Cross, H., Fernandez‐Ruiz, J., French, J., Hill, C., ... & Martinez‐Orgado, J. (2014). Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders. Epilepsia, 55(6), 791-802. https://doi.org/0.1111/epi.12631\n\nReferences\n\n\n                    Context: \n                    This chunk provides information on the legal status of cannabidiol in the United States, highlighting its legality under the 2018 Farm Bill and its classification under Schedule I of the Controlled Substances Act. It also includes external links and key literature references relevant to cannabidiol research and regulation, complementing the overall focus on CBD's effects, safety, and legal considerations within the full document.\n                "}
{"metadata": {"source": "erowid", "title": "Erowid Psilocybin & Psilocin Vault : Timeline", "description": "A timeline of events in the history of psilocybin & psilocin", "language": "No language found.", "url": "https://www.erowid.org/chemicals/psilocybin/psilocybin_timeline.php", "drug": "Psilocybin", "cid": 10624, "substance": "psilocybin", "category": "CHEMICALS", "erowid_column": "History", "char_count": 9960, "word_count": 1440, "doc_id": "doc_227", "num_chunks": 13, "chunk_id": "227::chunk_0", "document_index": 227, "latency_s": 0.7202739999920595, "prompt_toks": 3069, "completion_toks": 73, "relevance_score": 8.9209925e-07}, "content": "Drug: Psilocybin | cid: 10624\nSource: erowid | Source description: A timeline of events in the history of psilocybin & psilocin\nErowid name: psilocybin\nCategory: CHEMICALS\nField: History\n\n                    Text: \n                    Plants & Drugs Index\n\nPlants\n\n\n\nChemicals\n\n\n\nPharmaceuticals\n\n\n\nHerbs\n\n\n\nSmarts\n\n\n\nAnimals\n\n\n\nBasics\n\n\n\nImages\n\n\n\nExperiences\n\n\n\nLaw\n\n\n\nChemistry\n\n\n\nDrug Testing\n\n\n\nHealth\n\n\n\nSpirit & Culture\n\n\n\nCommunity\n\n\n\nPlants Vault\n\nAmanitas\n\nCacti\n\nCannabis\n\nCoca\n\nPsilocybin Mushrooms\n\nSalvia divinorum\n\nTobacco\n\nMore . . .\n\nChemicals Vault\n\nAmphetamine\n\nDXM\n\nGHB\n\nKetamine\n\nLSD\n\nMDMA\n\nNitrous\n\nMore . . .\n\nPharmaceuticals Vault\n\nAlprazolam (Xanax)\n\nBupropion (Wellbutrin)\n\nDiazepam (Valium)\n\nFluoxetine (Prozac)\n\nHydrocodone (Vicodin)\n\nMethylphenidate (Ritalin)\n\nParoxetine (Paxil)\n\nMore . . .\n\nHerbs Vault\n\nCalamus\n\nDamiana\n\nFoxglove\n\nGinseng\n\nMilk Thistle\n\nPennyroyal\n\nValerian\n\nMore . . .\n\nNootropics Vault\n\nAdrafinil\n\nDMAE\n\nGinkgo biloba\n\nHydergine\n\nMelatonin\n\nPiracetam\n\nTryptophan\n\nMore . . .\n\nAnimals Vault\n\nBufo Toads\n\nPhyllomedusa bicolor\n\nMore . . .\n\nBasics Vaults\n\nDosage\n\nEffects\n\nFAQs\n\nHistory\n\nSlang\n\nImage Vaults\n\nPlants\n\nChemicals\n\nPharmaceuticals\n\nHerbs\n\nSmarts\n\nSubmit Image\n\n\n                    Context: \n                    This chunk provides an overview of the main categories and vault sections within the Plants & Drugs Index on Erowid, including lists of specific plant species, chemicals, pharmaceuticals, herbs, nootropics, animals, and core topics like dosage, effects, history, and imagery, serving as a navigational guide to the site's extensive substance and cultural information.\n                "}
{"metadata": {"source": "psychonaut_CSV", "row": 36, "doc_id": "doc_265", "num_chunks": 38, "chunk_id": "265::chunk_28", "document_index": 265, "latency_s": 0.5939297000004444, "prompt_toks": 6056, "completion_toks": 41, "relevance_score": 8.714339e-07}, "content": "Drug: Unknown | cid: N/A\nSource: psychonaut_CSV | Source description: ?\n\n                    Text: \n                    - Thought acceleration\n- Thought connectivity - A signature effect. Thoughts may feel more fluid and interconnected than usual. May occur alongside conceptual thinking and creativity enhancement .\n- Thought loops - Typically occurs at higher doses, and at the peak of the experience. Often accompanied by ego loss . This effect may become exacerbated or triggered by cannabis or stimulants.\n- Time distortion - A signature effect. The user's perception of time may be strongly altered. Typically takes the form of time dilation, or the experience of time slowing down and passing much slower than it does while sober.\n- Wakefulness - Users report that it is difficult or impossible to go to sleep for up to 10 hours (or more) after LSD ingestion.\n- Addiction suppression [47] - Some research suggests LSD can be used to treat addiction. Anecdotally, many users report that psychedelics are helpful for this purpose.\nHistory and culture: \nLiterature:\n\n\n                    Context: \n                    This section details LSD's cognitive and psychological effects, including thought processes, perception of time, wakefulness, and potential therapeutic uses like addiction treatment, fitting within the broader discussion of its subjective and mental effects.\n                "}
